Evaluation of Safety and Efficacy of New Infant Formula in Infantile Colic

Inclusion Criteria: * Healthy term infants * Subjects appropriate for gestational age between 35 and 41 weeks * Subjects between 15-60 days old * Subjects with birth weight between 2500 and 4200 g and regular weight gain (≥150g / week) * Diagnosis of infantile colic according to modified Wessel criteria (Crying episodes lasting 3 or more hours/day and occurring at least 3 days/week for at least 1 week) * Subjects exclusively bottle-fed at study entrance * Day care of the child only by mother/father * Provide written informed consent in accordance with legal requirement Exclusion Criteria: * Neonatal problems (respiratory distress, asphyxia, Hypoglycaemia, sepsis, NEC) * Clinical evidence of chronic illness or gastrointestinal disorders (GER, gastroenteritis) * Assumption of any kind of medication (except vitamin D, vitamin K and fluoride prophylaxis) during the week before the beginning of the study and during the study period * Subjects receiving formula for special medical purposes * Exclusively breast-fed infants * Feeding of supplemental Pro- and/or Prebiotics two weeks prior to inclusion * Allergic diseases (manifest atopic dermatitis, cow's milk allergy) * Participation in any other clinical intervention